The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with Chronic Total Occlusion Evaluated by Clinical Outcome and Optical Coherence Tomography Imaging Analysis

We sought to determine the effects of the use of a Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent (Combo(®) DTS) in patients with chronic total occlusion (CTO) by evaluating clinical outcomes and by performing an optical coherence tomography (OCT) analysis. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Blessing, Recha, Ahoopai, Majid, Geyer, Martin, Brandt, Moritz, Zeiher, Andreas M., Münzel, Thomas, Wenzel, Philip, Gori, Tommaso, Dimitriadis, Zisis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794972/
https://www.ncbi.nlm.nih.gov/pubmed/33379321
http://dx.doi.org/10.3390/jcm10010080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794972/
https://www.ncbi.nlm.nih.gov/pubmed/33379321
http://dx.doi.org/10.3390/jcm10010080

Ejemplares similares